Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

The use of self‐expanding metallic urethral stents in the treatment of recurrent bulbar urethral strictures: long‐term results

The use of self‐expanding metallic urethral stents in the treatment of recurrent bulbar urethral... Objective To evaluate the effectiveness and long‐term results of using a self‐expanding metallic urethral stent (Urolume™, American Medical Systems, Minnetonka, MI, USA) to treat recurrent bulbar urethral strictures. Patients and methods Between 1990 and 1999, 65 stents were placed in 60 men (mean age 45.2 years, range 20–71) with a urethral stricture (mostly caused by trauma and present for a mean of 4.3 years, range 0.16–26) and who had previously undergone different unsuccessful treatments. Results During a mean (range) follow‐up of 3.8 (1–9) years the strictures in 52 of the 60 patients (87%) were treated successfully. All patients initially had postvoid dribbling incontinence, but this resolved in most within one week; 19 patients remain incontinent. Conclusion The Urolume is a cost‐effective alternative to other treatments for recurrent bulbar urethral strictures of whatever cause. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png BJU International Wiley

The use of self‐expanding metallic urethral stents in the treatment of recurrent bulbar urethral strictures: long‐term results

Loading next page...
 
/lp/wiley/the-use-of-self-expanding-metallic-urethral-stents-in-the-treatment-of-pMgv6vvgVb

References (34)

Publisher
Wiley
Copyright
Copyright © 2000 Wiley Subscription Services, Inc., A Wiley Company
ISSN
1464-4096
eISSN
1464-410X
DOI
10.1046/j.1464-410x.2000.00891.x
Publisher site
See Article on Publisher Site

Abstract

Objective To evaluate the effectiveness and long‐term results of using a self‐expanding metallic urethral stent (Urolume™, American Medical Systems, Minnetonka, MI, USA) to treat recurrent bulbar urethral strictures. Patients and methods Between 1990 and 1999, 65 stents were placed in 60 men (mean age 45.2 years, range 20–71) with a urethral stricture (mostly caused by trauma and present for a mean of 4.3 years, range 0.16–26) and who had previously undergone different unsuccessful treatments. Results During a mean (range) follow‐up of 3.8 (1–9) years the strictures in 52 of the 60 patients (87%) were treated successfully. All patients initially had postvoid dribbling incontinence, but this resolved in most within one week; 19 patients remain incontinent. Conclusion The Urolume is a cost‐effective alternative to other treatments for recurrent bulbar urethral strictures of whatever cause.

Journal

BJU InternationalWiley

Published: Oct 1, 2000

There are no references for this article.